New research co-authored by Duncan Watson-Parris of UC San Diego’s Scripps Institution of Oceanography and the Halıcıoğlu ...

Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc.

Xenetic (XBIO) Biosciences has extended its previously announced Research Funding and Option Agreement with The Scripps Research Institute to advance the development of the Company’s program on the ...

A coastal research and monitoring program led by UC San Diego’s Scripps Institution of Oceanography has been awarded a ...

To help address this growing challenge, scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel ...

Collaborative among FAU, Scripps, Max Planck and more intends to champion research, programming to make Palm Beach County hub ...

Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc ...

scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel regenerative medicines capable of repairing tissues ...

FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...